In CHI, abnormalities in the insulin secretory mechanism or glucose-sensing mechanism result in a failure to regulate pancreatic insulin secretion in response to hypoglycemic conditions (serum glucose level < 60 mg/dL). Here, INS is linked to congenital isolated hyperinsulinism.